Financhill
Buy
70

MNKD Quote, Financials, Valuation and Earnings

Last price:
$5.72
Seasonality move :
4.28%
Day range:
$5.58 - $5.81
52-week range:
$3.38 - $7.07
Dividend yield:
0%
P/E ratio:
59.34x
P/S ratio:
5.50x
P/B ratio:
--
Volume:
3.4M
Avg. volume:
3.7M
1-year change:
-16.69%
Market cap:
$1.7B
Revenue:
$285.5M
EPS (TTM):
$0.09

Analysts' Opinion

  • Consensus Rating
    MannKind Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $9.39, MannKind Corp. has an estimated upside of 67.96% from its current price of $5.59.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing -25.22% downside risk from its current price of $5.59.

Fair Value

  • According to the consensus of 8 analysts, MannKind Corp. has 67.96% upside to fair value with a price target of $9.39 per share.

MNKD vs. S&P 500

  • Over the past 5 trading days, MannKind Corp. has overperformed the S&P 500 by 4.28% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • MannKind Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • MannKind Corp. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter MannKind Corp. reported revenues of $82.1M.

Earnings Growth

  • MannKind Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MannKind Corp. reported earnings per share of $0.03.
Enterprise value:
1.7B
EV / Invested capital:
9.27x
Price / LTM sales:
5.50x
EV / EBIT:
22.05x
EV / Revenue:
5.36x
PEG ratio (5yr expected):
1.74x
EV / Free cash flow:
39.36x
Price / Operating cash flow:
40.37x
Enterprise value / EBITDA:
19.36x
Gross Profit (TTM):
$235.9M
Return On Assets:
6.72%
Net Income Margin (TTM):
9.32%
Return On Equity:
--
Return On Invested Capital:
24.75%
Operating Margin:
22.86%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $176.5M $267.2M $313.8M $70.1M $82.1M
Gross Profit $115.7M $192.1M $235.9M $52.1M $61.9M
Operating Income -$9.4M $57.3M $76.3M $15.2M $18.8M
EBITDA -$3.8M $65.1M $86.9M $17.8M $21.5M
Diluted EPS -$0.12 $0.07 $0.09 $0.04 $0.03
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $159.2M $218.4M $225.6M $327.7M $358.8M
Total Assets $238.2M $293.8M $320.3M $464.2M $494.6M
Current Liabilities $50M $59.6M $96.4M $72.1M $109.1M
Total Liabilities $422.9M $531.5M $572.1M $674.1M $539.2M
Total Equity -$184.7M -$237.7M -$251.8M -$209.9M -$44.6M
Total Debt $287.5M $383.6M $382.4M $344.9M $187.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $9.9M $41.2M $48.2M $9.3M $23.5M
Cash From Investing $20.9M -$152.8M $35.4M -$41.3M -$25.1M
Cash From Financing -$2.1M $91.6M -$18.6M -$2.3M $72M
Free Cash Flow -$31.8M $28.5M $42.7M $7.8M $22.4M
MNKD
Sector
Market Cap
$1.7B
$28.4M
Price % of 52-Week High
79.07%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
1.42%
-1.32%
1-Year Price Total Return
-16.69%
-22.19%
Beta (5-Year)
0.821
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $5.36
200-day SMA
Buy
Level $4.74
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Buy
Level $5.32
Relative Strength Index (RSI14)
Buy
Level 63.26
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -23.2558
50-day SMA
Buy
Level $5.37
MACD (12, 26)
Buy
Level 0.03
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-7.0402)
Sell
CA Score (Annual)
Level (-3.5074)
Sell
Beneish M-Score (Annual)
Level (-1.1939)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.5596)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Stock Forecast FAQ

In the current month, MNKD has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNKD average analyst price target in the past 3 months is $9.39.

  • Where Will MannKind Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that MannKind Corp. share price will rise to $9.39 per share over the next 12 months.

  • What Do Analysts Say About MannKind Corp.?

    Analysts are divided on their view about MannKind Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MannKind Corp. is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is MannKind Corp.'s Price Target?

    The price target for MannKind Corp. over the next 1-year time period is forecast to be $9.39 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MNKD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for MannKind Corp. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of MNKD?

    You can purchase shares of MannKind Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MannKind Corp. shares.

  • What Is The MannKind Corp. Share Price Today?

    MannKind Corp. was last trading at $5.72 per share. This represents the most recent stock quote for MannKind Corp.. Yesterday, MannKind Corp. closed at $5.59 per share.

  • How To Buy MannKind Corp. Stock Online?

    In order to purchase MannKind Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
64
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock